The trk Proto-Oncogene Product: a Signal Transducing Receptor for Nerve Growth Factor-Reference-Cited by-同舟云学术

The trk Proto-Oncogene Product: a Signal Transducing Receptor for Nerve Growth Factor

Published:1991-04-26 Issue:5005 Volume:252 Page:554-558
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Kaplan David R.¹,Hempstead Barbara L.²,Martin-Zanca Dionisio³,Chao Moses V.²,Parada Luis F.³

Affiliation:

1. Eukaryotic Signal Transduction Group, Advanced Biosciences Laboratory-Basic Research Program, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, MD 21702.

2. Hematology-Oncology Division, Department of Medicine and Department of Cell Biology and Anatomy, Cornell University Medical College, New York, NY 10021.

3. Molecular Embryology Group, Advanced Biosciences Laboratory-Basic Research Program, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, MD 21702.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference57 articles.

1. BANERJEE, U, MOLECULAR CHARACTERIZATION AND EXPRESSION OF SEVENLESS, A GENE INVOLVED NEURONAL PATTERN-FORMATION IN THE DROSOPHILA EYE, CELL 49: 281 (1987).

2. BARDE, Y.A., TROPHIC FACTORS AND NEURONAL SURVIVAL, NEURON 2: 1525 (1989).

3. Basler, K., Trends in Genetics 4: 74 (1988).

4. BLACK, I.B., CURR TOP DEV BIOL 24: 161 (1990).

5. BOTHWELL, M.A., CLONAL VARIANTS OF PC12 PHEOCHROMOCYTOMA CELLS WITH ALTERED RESPONSE TO NERVE GROWTH-FACTOR, CELL 21: 857 (1980).

Cited by 1243 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nerve growth factor receptor limits inflammation to promote remodeling and repair of osteoarthritic joints;Nature Communications;2024-04-15

2. Clinical and genetic characteristics of three patients with congenital insensitivity to pain with anhidrosis: Case reports and a review of the literature;Molecular Genetics & Genomic Medicine;2024-04

3. Next-generation therapies for pancreatic cancer;Expert Review of Gastroenterology & Hepatology;2024-02-28

4. Design of new small molecules derived from indolin-2-one as potent TRKs inhibitors using a computer-aided drug design approach;Journal of Biomolecular Structure and Dynamics;2024-01-13

5. The p75 neurotrophin receptor;HIV-Associated Neurocognitive Disorders;2024